Dimerix Ltd (ASX: DXB) — Healthcare · Share Price, Chart & Market Data
About: Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. It develops DMX-200 for the treatment of focal segmental glomerulosclerosis disease, diabetic kidney disease, and ARDS associated with COVID-19; and DMX-700 for orphan respiratory/renal disease, as well as proprietary Receptor-HIT assay technology. The company is headquartered in Fitzroy, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.39 (+2.63%)
DXBDimerix Ltd
Loading watchlist status…
Trade DXB now
Dimerix Ltd share price
DXB price activity
Last Price
Change (24hr)
AUD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 11:53 am GMT+0
DXB price performance
2.632%
5D
20%
1M
-29.091%
YTD
-18.75%
1Y
DXB price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
ASX rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 11:53 am GMT+0
DXB details
DXB Market Signals